IRIS
BUONERBA, CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.132
EU - Europa 620
AS - Asia 378
AF - Africa 41
Totale 2.171
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.115
IT - Italia 268
SG - Singapore 162
CN - Cina 112
NL - Olanda 111
VN - Vietnam 56
GB - Regno Unito 46
UA - Ucraina 45
CI - Costa d'Avorio 39
DE - Germania 37
IN - India 36
IE - Irlanda 35
SE - Svezia 31
FI - Finlandia 25
CA - Canada 17
BE - Belgio 5
FR - Francia 5
CZ - Repubblica Ceca 4
DK - Danimarca 4
HK - Hong Kong 4
IR - Iran 3
MA - Marocco 2
AT - Austria 1
BN - Brunei Darussalam 1
CH - Svizzera 1
HR - Croazia 1
JP - Giappone 1
KZ - Kazakistan 1
NP - Nepal 1
RS - Serbia 1
TR - Turchia 1
Totale 2.171
Salva come PNG Salva come JPEG
Città #
Chandler 207
Singapore 130
Naples 113
Amsterdam 111
Ashburn 93
Millbury 59
Dong Ket 56
Beijing 39
Lawrence 38
Boston 36
Napoli 34
Des Moines 33
Princeton 27
Nanjing 22
Wilmington 21
Santa Clara 17
Washington 16
Ottawa 15
Dallas 11
Dublin 9
Fairfield 8
Hebei 8
Nanchang 8
Seattle 8
Caserta 6
Jacksonville 6
Norwalk 6
Redwood City 6
Shenyang 6
Boardman 5
Changsha 5
Los Angeles 5
Milan 5
Rome 5
Woodbridge 5
Brno 4
Courcelles 4
Dearborn 4
Hong Kong 4
Houston 4
Kronberg 4
Tianjin 4
Abidjan 3
Ann Arbor 3
Ardabil 3
Augusta 3
Aversa 3
Catania 3
Falls Church 3
New York 3
Pune 3
Asti 2
Dalmine 2
Kochi 2
Kunming 2
Latina 2
Locate di Triulzi 2
Monmouth Junction 2
Pescara 2
Piana 2
Pontedera 2
Rovereto 2
Saint-Fons 2
Salerno 2
Shanghai 2
Shenzhen 2
Tronzano Vercellese 2
Acerra 1
Agadir 1
Bandar Seri Begawan 1
Brussels 1
Casablanca 1
Chicago 1
Cinisello Balsamo 1
Clifton 1
Cormeilles-en-Parisis 1
Crispano 1
Darmstadt 1
Edinburgh 1
Florence 1
Frankfurt am Main 1
Ghedi 1
Gunzenhausen 1
Hangzhou 1
Hanover 1
Hefei 1
Indiana 1
Jenera 1
Jiaxing 1
Jinan 1
Kathmandu 1
Leawood 1
Macerata Campania 1
Manassas 1
Marcianise 1
Mondragone 1
Mugnano Di Napoli 1
Mumbai 1
Novi Sad 1
Nürnberg 1
Totale 1.299
Salva come PNG Salva come JPEG
Nome #
Durability of Humoral Immune Responses to SARS-CoV-2 in Citizens of Ariano Irpino (Campania, Italy): A Longitudinal Observational Study With an 11.5-Month Follow-Up 143
Incidence of fatigue and low-dose corticosteroid use in prostate cancer patients receiving systemic treatment: a meta-analysis of randomized controlled trials 53
Urotensin II receptor on preoperative biopsy is associated with upstaging and upgrading in prostate cancer 52
A comprehensive outlook on inracerebral therapy of malignant gliomas 52
Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: A systematic review and meta-analysis 46
A third-line sorafenib aftrer sequential therapy with sunitinib and mTOR inhibitors in methastatic renal cell carcinoma 45
Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-Line Sunitinib (QUASAR): Results of a Phase I Trial 45
Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicentre study 44
Can high-dose fotemustine reverse MGMT resistance in glioblastoma multiforme? 42
Correlative Imaging in a Patient with Cystic Thymoma: CT, MR and PET/CT Comparison. 42
Castration-resistant prostate cancer: current and emerging treatment strategies 41
The use of chest ultrasonography in suspected cases of COVID-19 in the emergency department 41
Modified glasgow prognostic score is associated with risk of recurrence in bladder cancer patients after radical Cystectomy: A multicenter experience 40
Biomarkers in localized prostate cancer 40
Outcomes Associated with First-Line anti-PD-1/ PD-L1 agents vs. Sunitinib in Patients with Sarcomatoid Renal Cell Carcinoma: A Systematic Review and Meta-Analysis 40
Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette–Guérin after transurethral resection of the bladder tumor 40
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma 38
Combined bone scintigraphy and fluorocholine PET/computed tomography predicts response to radium-223 therapy in patients with prostate cancer 38
A long-lasting response to sorafenib treatment in an advanced hepatocellular carcinoma patient. 37
Predicting pathological features at radical prostatectomy in patients with prostate cancer eligible for active surveillance by multiparametric magnetic resonance imaging 37
Efficacy of rituximab in gastric diffuse large B cell Lymphoma patients. 36
Soluble interleukin-6 receptor to interleukin-6 (sIL-6R/IL-6) ratio in serum as a predictor of high Gleason sum at radical prostatectomy 36
Assessment of Total, PTEN–, and AR-V7+ Circulating Tumor Cell Count by Flow Cytometry in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide 36
The tnfrsf13c h159y variant is associated with severe covid-19: A retrospective study of 500 patients from southern italy 36
Docetaxel Rechallenge in a Heavily Pretreated Patient with Castration-Resistant Prostate Cancer 35
Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patients 34
Clinical and Pathological Characteristics of Metastatic Renal Cell Carcinoma Patients Needing a Second-Line Therapy: A Systematic Review 34
Seroprevalence of SARS-CoV-2 Assessed by Four Chemiluminescence Immunoassays and One Immunocromatography Test for SARS-Cov-2 34
Combination of docetaxel and cetuximab for penile cancer: a case report and literature review 33
Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance 33
Locally advanced paranasal sinus carcinoma: A study of 30 patients 33
Three vs. Four Cycles of Neoadjuvant Chemotherapy for Localized Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Multi-Institutional Analysis 33
Comparing cardiovascular adverse events in cancer patients: A meta-analysis of combination therapy with angiogenesis inhibitors and immune checkpoint inhibitors versus angiogenesis inhibitors alone 32
Lack of cumulative toxicity associated with cabazitaxel use in prostate cancer 32
Clinical factors affecting prostate-specific antigen levels in prostate cancer patients undergoing radical prostatectomy: a retrospective study 32
Imatinib mesylate in thymic epithelial malignancies. 31
The evolving role of monoclonal antibodies in the treatment of patients with advanced renal cell carcinoma: a systematic review 31
Predictors of residual T1 high grade on re-transurethral resection in a large multi-institutional cohort of patients with primary T1 high-grade/grade 3 bladder cancer 31
Perspective: Cancer Patient Management Challenges During the COVID-19 Pandemic 31
A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy 31
Germline rare variants of lectin pathway genes predispose to asymptomatic SARS-CoV-2 infection in elderly individuals 31
The emerging role of obesity, diet and lipid metabolism in prostate cancer 30
Metabolomic profiling for the identification of novel diagnostic markers and therapeutic targets in prostate cancer: an update 30
Clinical Characteristics of Metastatic Prostate Cancer Patients Infected with COVID-19 in South Italy 30
Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor 29
Paclitaxel in pretreated metastatic penile cancer: final results of a phase 2 study. 28
Rapidly progressive disease in a castration-resistant prostate cancer patient after cabazitaxel discontinuation 28
The use of 68Ga prostate-specific membrane antigen PET-CT in prostate cancer: diagnostic challenges and therapeutic opportunities 28
Increased Body Mass Index Is a Risk Factor for Poor Clinical Outcomes after Radical Prostatectomy in Men with International Society of Urological Pathology Grade Group 1 Prostate Cancer Diagnosed with Systematic Biopsies 28
An adjusted indirect comparison of everolimus andsorafenib therapy in sunitinib-refractory metastatic renal cell carcinoma patients using repeated matched samples 27
Phase II Study of docetaxel re-treatment in docetaxel-pretreated castration-resistant prostate cancer 26
Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy 26
Regulatory noncoding and predicted pathogenic coding variants of ccr5 predispose to severe covid-19 26
Seroprevalence of SARS-CoV-2-specific antibodies in the town of Ariano Irpino (Avellino, Campania, Italy): A population-based study 26
COVID-19 and prostate cancer: A complex scenario with multiple facets 25
First-line systemic therapy for metastatic castration-sensitive prostate cancer: An updated systematic review with novel findings 24
Kaempferol, myricetin and fisetin in prostate and bladder cancer: A systematic review of the literature 24
Liquid biopsy biomarkers in urine: A route towards molecular diagnosis and personalized medicine of bladder cancer 22
Liquid biopsy in bladder cancer: State of the art and future perspectives 21
High-dose fotemustine in temozolomide-pretreated glioblastoma multiforme patients 20
Dysregulated metabolism: A relevant player in prostate cancer progression and clinical management 20
Urologic malignancies: advances in the analysis and interpretation of clinical findings 20
Ten-year adjuvant treatment with somatostatin analogs in a patient with atypical carcinoid of the lung. 18
Second line trastuzumab emtansine following horizontal dual blockade in a real-life setting 18
Fascin-1 and its role as a serological marker in prostate cancer: A prospective case-control study 16
Statin use and survival in patients with metastatic castrationresistant prostate cancer treated with abiraterone or enzalutamide after docetaxel failure: The international retrospective observational STABEN study 13
Instant messaging in cancer care 9
Time to progression is the main predictor of survival in patients with high-risk nonmuscle invasive bladder cancer: Results from a machine learning-based analysis of a large multi-institutional database 9
Predictors of Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Urothelial Carcinoma: A Systematic Review and Meta-Analysis 7
Current imaging evaluation of tumor response to advanced medical treatment in metastatic renal-cell carcinoma: Clinical implications 4
Unraveling the Dietary Puzzle: Exploring the Influence of Diet, Nutraceuticals, and Supplements on Bladder Cancer Risk, Outcomes, and Immunotherapy Efficacy: Insights from the BLOSSOM Study and Beyond 3
Totale 2.286
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.695
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.695
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202090 0 0 1 3 1 4 8 9 3 18 36 7
2020/2021192 7 2 10 6 14 22 10 1 14 11 23 72
2021/2022556 20 6 10 2 3 5 8 13 144 45 159 141
2022/2023611 66 25 33 15 73 62 8 63 100 112 46 8
2023/2024472 12 67 85 36 25 55 3 64 24 7 61 33
2024/2025198 101 96 1 0 0 0 0 0 0 0 0 0
Totale 2.286